(Q34280867)

1 August 2017

1 reference

title

Contemporary drug therapy in palliative care: new directions (English)

1 reference

1 August 2017

D'Olimpio J

1

1 reference

1 August 2017

publication date

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

19

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

413-423

1 reference

Patient preferences for oral versus intravenous palliative chemotherapy

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Use of the subcutaneous route for the administration of narcotics in patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Pharmacologic treatment of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Impact of environmental and genetic factors on codeine analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Individual variability in the response to different opioids: report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

The analgesic activity of morphine-6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Disposition of morphine-6-glucuronide and morphine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Morphine-6-glucuronide, a potent mu agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Morphine-6-glucuronide has high affinity for the opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Caroli's disease misdiagnosed as hydatid liver cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

The history and development of the fentanyl series

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

An open label study of oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

An update on the clinical use of methadone for cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Body-composition changes in patients who gain weight while receiving megestrol acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Thalidomide: rationale for renewed use in immunological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

The use of nebulized opioids for breathlessness: a chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-100103135

21 January 2018

Identifiers

DOI

10.1081/CNV-100103135

1 reference

1 August 2017

1 reference